Activated prothrombin complex concentrate for dabigatran-associated bleeding

British Journal of Haematology

Volumn 164, Issue 2, 2014, Pages 308-310

  Schulman, Sam ^a   Ritchie, Bruce ^b   Goy, Jennifer K ^a   Nahirniak, Susan ^b   Almutawa, Mohammad ^b   Ghanny, Shari ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Bleeding activated prothrombin complex concentrate; Dabigatran

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; DABIGATRAN;

AGED; BASAL GANGLION HEMORRHAGE; BLEEDING; BLOOD PRESSURE MEASUREMENT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CRANIOTOMY; CREATININE CLEARANCE; DISEASE ASSOCIATION; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; INTERNATIONAL NORMALIZED RATIO; LETTER; MALE; MEDICAL HISTORY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; SLURRED SPEECH; SUBDURAL HEMATOMA; SURGICAL DRAINAGE; THROMBIN TIME; UPPER GASTROINTESTINAL BLEEDING; VERY ELDERLY;

BLEEDING ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE; DABIGATRAN;

AGED, 80 AND OVER; ANTITHROMBINS; BENZIMIDAZOLES; BETA-ALANINE; BRAIN; FEMALE; HEMATOMA, SUBDURAL; HEMORRHAGE; HUMANS; MALE; PROTHROMBIN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84891634652     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12620     Document Type: Letter

References (10)

1. Cotton, B.A., McCarthy, J.J. & Holcomb, J.B. (2011) Acutely injured patients on dabigatran. New England Journal of Medicine, 365, 2039-2040.
2. Dager, W.E., Gosselin, R.C. & Roberts, A.J. (2013) Reversing dabigatran in a life-threatening bleed occurring during cardiac ablation with factor eight inhibitor bypassing activity. Critical Care Medicine, 41, e42-e46.
3. Elg, M., Carlsson, S. & Gustafsson, D. (2001a) Effects of activated prothrombin complex concentrate or recombinant factor VIIa on bleeding time and thrombus formation during anticoagulation with a direct thrombin inhibitor. Thrombosis Research, 101, 145-157.
4. Elg, M., Carlsson, S. & Gustafsson, D. (2001b) Effects of agents, used to treat bleeding disorders, on bleeding time prolonged by a very high dose of a direct thrombin inhibitor in anesthesized rats and rabbits. Thrombosis Research, 101, 159-170.
5. Hoffman, M. & Dargaud, Y. (2012) Mechanisms and monitoring of bypassing agent activity. Journal of Thrombosis and Haemostasis, 10, 1478-1485.
6. Khadzhynov, D., Wagner, F., Formella, S., Wiegert, E., Moschetti, V., Slowinski, T., Neumayer, H.H., Liesenfeld, K.H., Lehr, T., Hartter, S., Friedman, J., Peters, H. & Clemens, A. (2013) Effective elimination of dabigatran by haemodialysis. A phase I single-centre study in patients with end-stage renal disease. Thrombosis and Haemostasis, 109, 596-605.
7. Lillo-Le Louet, A., Wolf, M., Soufir, L., Galbois, A., Dumenil, A.S., Offenstadt, G. & Samama, M.M. (2012) Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: implications for emergency surgery and resuscitation. Thrombosis and Haemostasis, 108, 583-585.
8. Majeed, A. & Schulman, S. (2013) Bleeding and antidotes in new oral anticoagulants. Best Pract Res Clin Haematol, 26, 191-202.
9. van Ryn, J., Schurer, J., Kink-Eiband, M. & Clemens, A. (2011) The successful reversal of dabigatran-induced bleeding by coagulation factor concentrates in a rat tail bleeding model do not correlate with ex vivo markers of anticoagulation. Blood (ASH Annual Meeting Abstracts), 118, 2316.
10. Schiele, F., van Ryn, J., Canada, K., Newsome, C., Sepulveda, E., Park, J., Nar, H. & Litzenburger, T. (2013) A specific antidote for dabigatran: functional and structural characterization. Blood, 121, 3554-3562.